Zoretanin

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Zoretanin

Property Description
Active Ingredient Isotretinoin (13-cis-retinoic acid)
Form Oral soft gelatin capsules
Pharmacological Class Systemic Retinoid (Vitamin A derivative)
Type Single-ingredient, Prescription-Only
General Purpose Corrective action on sebaceous gland function

What Type of Medicine is Zoretanin (Isotretinoin)?

Zoretanin is a brand name for a potent, prescription-only medicine whose active ingredient is Isotretinoin, known chemically as 13-cis-retinoic acid. It is firmly established within the pharmacological class of retinoids, which are specialized synthetic derivatives of Vitamin A (retinol). Isotretinoin is indicated for treating dermatological conditions that are severe and resistant to other therapeutic approaches. This reflects the drug's role as a highly specialized, foundational treatment.

The medication is an oral medicine typically delivered in a soft gelatin capsule, distinguishing it as a systemic treatment that modifies biological processes throughout the body. The general use scenario for this drug involves adult and adolescent patients who have exhausted conventional treatment courses, highlighting its positioning as a powerful, advanced therapeutic agent in dermatology.

Composition, Origin, and Unique Chemical Nature

The composition of Zoretanin is defined by the single active ingredient, Isotretinoin, formulated with a lipophilic base such as soybean oil to facilitate maximum absorption following oral intake. While it is manufactured as a synthetic retinoid, Isotretinoin is also an endogenous metabolite—a substance naturally found in small quantities within the human body.

Its unique mechanism is one of systemic regulation, differentiating it from treatments such as conventional oral antibiotics. Retinoids function as regulators of cell growth and differentiation. This clinically recognized property verifies that the drug's core purpose is to correct biological function at the cellular level.

General Purpose and Fundamental Action on Skin Function

The general purpose of this medicine is to provide a long-term corrective solution for challenging and persistent dermatological issues. Zoretanin achieves this through two fundamental actions: the profound regulation of oil production and the normalization of skin cell behavior.

Its core effect involves dramatically shrinking the size of the skin's sebaceous glands, leading to a significant reduction in the output of sebum (skin oil). Furthermore, it acts as a keratolytic agent by ensuring skin cells mature and shed properly, preventing them from clogging pores and follicles. This combined, powerful approach eliminates the excess oil and blocked follicles, which are the fundamental causes driving the development of the most severe types of skin pathology.

What side effects are possible with Zoretanin?

Possible Side Effects and Safety Information

The official safety profile for Zoretanin (Isotretinoin) organizes potential adverse effects by frequency and the body system affected, based on regulatory documentation from authorities like the EMA and FDA. The most frequently documented reactions are systemic, often reflecting the drug's properties as a retinoid.


Frequency-Classified Adverse Reactions

The frequency classification below reflects occurrence rates cited in regulatory documents:

  • Very Common (Affecting ge 1 in 10 individuals): Reactions affecting the Skin and Mucosa are most prevalent, including cheilitis (lip inflammation), dry skin, dryness of the nasal mucosa, and epistaxis (nosebleeds). Ocular effects such as dry eyes and conjunctivitis, as well as musculoskeletal effects like back pain and arthralgia (joint pain), are also classified as Very Common. Changes to laboratory values such as elevated blood triglycerides and liver transaminases are frequently observed.

  • Common (Affecting ge 1 in 100 individuals): Headache, alopecia (hair loss), dermatitis, and pruritus (itching).

  • Rare/Very Rare (Affecting < 1 in 1,000 to < 1 in 10,000 individuals): These categories include serious adverse reactions affecting various systems.


Serious Adverse Reactions and Safety Restrictions

Official labeling documents specific, potentially serious reactions classified as Rare or Very Rare. These include serious psychiatric effects (e.g., depression, suicidal ideation), inflammatory bowel disease (colitis/ileitis), pancreatitis, and Benign Intracranial Hypertension (Pseudotumor Cerebri). Additionally, severe skin reactions such as Stevens-Johnson Syndrome are documented.

Safety is further defined by official restrictions. Use is contraindicated in individuals with severe hepatic impairment or markedly elevated blood lipids. Concurrent use with tetracyclines or Vitamin A supplements is also restricted due to the increased risk of specific toxicities.

Time and Population Safety Notes

Safety notes specify that a temporary exacerbation of acne and systemic dryness effects are frequent at the start of treatment. Furthermore, the label notes that skeletal changes, such as hyperostosis, are associated with long-term administration. Specific considerations are documented for populations, including the requirement for a lower initial dose in patients with renal impairment.

Overdose and Emergency Response

Overdose and When to Seek Help

Acute overdose of Zoretanin (Isotretinoin) is officially documented to result in clinical manifestations consistent with Hypervitaminosis A. These presentations commonly include a severe headache, nausea, vomiting, and dizziness, along with skin signs such as facial flushing and cheilitis (inflamed lips).

The most severe, regulator-listed risk associated with acute toxicity involves the Central Nervous System. This may lead to the development of pseudotumor cerebri (benign intracranial hypertension), which requires immediate attention due to the potential for severe headache and visual disturbance. Cases of massive acute ingestion have the potential to cause loss of consciousness.

Regulatory guidance is explicit that individuals must seek immediate medical attention and contact a poison control center immediately upon any suspicion or confirmation of an overdose. The official management strategy is strictly symptomatic and supportive treatment, as the labeling confirms that no specific antidote is known for Isotretinoin. Procedures like gastric lavage may be considered by medical professionals for recent ingestion. Acute toxicity is generally documented as being reversible upon the withdrawal of the drug, but hospital monitoring is required to manage any serious CNS effects.

Therapeutic Uses of Zoretanin

What Zoretanin Treats: Main Uses and Benefits

Managing Severe, Recalcitrant Symptoms

The medication is commonly used to help manage severe recalcitrant nodular acne, a condition characterized by deep, painful lesions (nodules and cysts). This treatment is typically indicated where additional symptomatic support is needed for patients whose symptoms may not have improved after other supportive symptomatic approaches, such as systemic antibiotics. It is relevant in clinical settings that involve acute or disruptive episodes of severe acne, and it may assist with the management of these chronic, painful manifestations.

Supporting Long-Term Stability and Easing Disfigurement Risk

This medicine is considered relevant for managing symptoms that interfere with daily comfort due to the high risk of permanent disfigurement. It is considered relevant in conditions presenting with severe nodular or cystic acne or acne at risk of permanent scarring. The therapy is applied when appropriate for the most severe, tissue-destructive inflammation, which helps support improved comfort by assisting with the reduction of severe inflammation, thereby lessening the risk of developing permanent scarring and supporting general well-being during symptomatic phases.


Relevant Context: Use for Refractory Symptoms

The medication is typically applied in clinical settings that involve acute or unstable symptom patterns, offering supportive relief when symptoms become temporarily overwhelming due to their resistance to standard treatments.

Eligibility and Restrictions for Use

The use of Zoretanin (Isotretinoin) is strictly regulated, with several populations designated as formally contraindicated in official prescribing information.

Absolute Contraindications

The medicine must not be used by:

  • Female patients who are pregnant or may become pregnant. This is an absolute prohibition (Category X) due to the extremely high risk of severe birth defects (teratogenicity).
  • Female patients who are breastfeeding.
  • Patients with hypersensitivity to isotretinoin or any component, including those with known allergies to soya or peanuts (related to excipients).
  • Patients with severe hepatic insufficiency (liver disease), hypervitaminosis A, or excessively high blood lipid values.
  • Patients receiving concomitant treatment with tetracyclines.

Age and Restricted Use

  • Approved Age: Use is indicated only for non-pregnant patients 12 years of age and older. Safety and efficacy are not established in children younger than 12.
  • Conditional Use: Female patients of childbearing potential must enroll in a mandatory risk management program (e.g., iPLEDGE) and commit to using two effective forms of contraception for the entire period of use and for one month before and after treatment.
  • Special Consideration: Use requires caution in patients with severe renal impairment (kidney disease), diabetes, or a history of lipid metabolism disorder.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Regulatory authorities classify specific combinations with Isotretinoin, the active ingredient in Zoretanin, as highly restricted due to the risk of additive toxicity and other pharmacodynamic effects.

Contraindicated and High-Risk Combinations

Interaction Entity Official Regulatory Restriction
Tetracycline Antibiotics Co-administration is formally contraindicated due to the serious additive risk of Pseudotumor Cerebri (Benign Intracranial Hypertension).
Vitamin A Supplements Must be avoided concurrently due to the significant danger of additive toxic effects that can lead to Hypervitaminosis A symptoms.
Other Systemic Retinoids Co-use is restricted due to shared pathways that increase the risk of systemic retinoid-related adverse effects.

Pharmacokinetic and Substance Interactions

The absorption and plasma exposure of Zoretanin are significantly increased when administered with a high-fat meal, which is a key pharmacokinetic modification noted in regulatory information. The concurrent consumption of alcohol requires caution as it may heighten the risk of hypertriglyceridemia, particularly in patients with existing lipid metabolism concerns.

Additionally, the herbal product St. John's Wort is relevant due to its documented potential to compromise the efficacy of oral contraceptives, which are mandatory co-administered medications for female patients of childbearing potential during this therapy.

Mechanism of Action

Zoretanin (isotretinoin) is a synthetic derivative of vitamin A (a retinoid) that exerts its primary effects on the sebaceous glands and the pilosebaceous unit. Upon systemic administration, it is selectively concentrated in the sebum and skin. The drug acts as a prodrug, undergoing isomerization in vivo to all-trans retinoic acid (ATRA), which is the high-affinity agonist for nuclear Retinoic Acid Receptors (RARs), particularly RAR-gamma.

Binding of the ATRA-RAR heterodimer complex to Retinoic Acid Response Elements (RAREs) in the nucleus modulates gene transcription. This modification in gene expression is coupled with the upregulation of pro-apoptotic transcription factors, specifically FoxO1 and FoxO3a. The subsequent increase in apoptotic signaling molecules, such as TRAIL (TNF-related apoptosis-inducing ligand) and IGFBP-3 (Insulin-like growth factor-binding protein 3), triggers the cascade for programmed cell death in the sebocytes. This sebocyte apoptosis leads to a substantial reduction in the size of the sebaceous glands and, consequently, decreased production and secretion of sebum. Additionally, Zoretanin modulates keratinocyte differentiation within the follicular epithelium, counteracting epithelial hyperproliferation. System-level consequences include modulation of systemic inflammation markers, such as a decrease in inflammatory cytokines and suppressed neutrophil chemotaxis.

Dosage and Administration Information

How Zoretanin (Isotretinoin) is Used

Zoretanin, an oral systemic retinoid, is administered following weight-based protocols. This medicine is available in strengths such as 10 mg and 20 mg soft gelatin capsules, which constitute the oral route of administration.


Official Dosing and Schedule

Instruction Entity Official Requirement/Pattern
Starting Daily Dose Generally 0.5 mg/kg/day (milligrams per kilogram of body weight per day) for adults and adolescents (12 years).
Frequency and Timing The total daily dose is typically administered in two divided doses. Capsules are taken with a meal or fatty snack to facilitate drug absorption.
Course Duration A single course typically lasts 15 to 20 weeks, aiming for a total cumulative dose of 120 to 150 mg/kg.

Administration Requirements

The capsules are designed to be swallowed whole with a liquid and are not crushed, chewed, or opened. The dose may be adjusted within the 0.5 to 1.0 mg/kg/day range based on clinical response, and cases involving very severe symptoms may involves doses up to 2.0 mg/kg/day. If a dose is missed, the standard procedure is to skip that dose and resume the regular schedule without doubling the next dose. If a second course is considered, a minimum waiting period of two months off therapy is generally observed to evaluate the full therapeutic response.

Recent Clinical Evidence

Research Evidence: Overview of Studies for Zoretanin (Isotretinoin)

Evidence for Use in Severe Recalcitrant Nodular Acne

The evidence base for Zoretanin has been established through Randomized Controlled Trials (RCTs) and comprehensive meta-analyses that integrate results from numerous studies. This research has primarily explored the medicine's clinical evaluation for severe, treatment-resistant forms of acne characterized by deep, painful nodules and cysts. The trials examined outcomes such as changes in the total count of inflammatory lesions and patient-reported quality of life measures.

Long-Term Study Durability and Follow-Up

Long-term research focuses on the durability of measured changes following treatment, often monitoring participants for one to five years or longer. A critical area of study is the risk of acne relapse or recurrence. Recent large-scale cohort studies have indicated that a higher cumulative dosage of the medicine was associated with reduced rates of acne relapse and retrial of the medicine. However, these studies also observed variability in relapse rates, and research suggests that the maximum daily dose did not consistently influence the risk of relapse when cumulative dosage was adequate.

Evidence on Scarring Risk and Tissue Preservation

Research on scarring risk primarily consists of observational and retrospective cohort studies that look at patients with severe, inflammatory acne who are at risk of permanent disfigurement. Findings describe patterns where the measured clearance achieved during the acute treatment phase was observed in patients with a lower subsequent incidence of new scarring. For pre-existing scars, studies often report variable and minimal objective changes during the treatment period itself.

What Remains Uncertain: Research Gaps and Limitations

While the evidence base is substantial for acute outcomes, several areas require further study. Long-term certainty regarding individual patient outcomes and relapse prediction is not fully established, and direct comparative controlled trials assessing the optimal cumulative dose and its long-term effects across all subgroups are limited. Consistency in outcomes is affected by research heterogeneity in dosing protocols and differing definitions of acne relapse.

Frequently Asked Questions (FAQ)

Common questions about Zoretanin (FAQ)

Q: Is Zoretanin the same thing as Roaccutane or Accutane?

Zoretanin is a brand name for the active ingredient isotretinoin. According to official product information, isotretinoin is marketed globally under many different brand names, including well-known names like Accutane and Roaccutane. These medicines contain the same core active ingredient.


Q: How quickly does Zoretanin usually start to show an effect?

Regulatory guidance notes that it is common for a patient’s acne to experience a temporary worsening (or flare-up) during the first few weeks of treatment. Measurable improvement is typically observed after one to two months, though the exact time frame can vary significantly between individuals.


Q: Is Zoretanin only used for severe acne?

The primary approved use of this medicine is for the treatment of severe, disfiguring nodular acne that has not responded to other forms of therapy. Official documents also mention that the medicine may be used to treat certain other severe skin diseases. The use of the medicine for other conditions is based on a healthcare professional's assessment.


Q: Are the side effects of Zoretanin permanent?

Most common side effects resolve when treatment is stopped. However, official safety information indicates that rare instances of decreased night vision have been reported to persist after therapy was discontinued. Monitoring and assessment for these rare, serious effects may continue after treatment has ended.


Q: Are there any foods I should avoid while on Zoretanin?

Official regulatory warnings emphasize that you must strictly avoid taking vitamin A supplements or any multivitamins that contain Vitamin A. This is because combining them with the medicine can cause additive toxic effects and lead to a condition known as Hypervitaminosis A. Regulatory documents do not detail restrictions on everyday foods.


Q: What are the blood tests required before starting Zoretanin?

Blood tests are required before starting treatment to establish baseline values, particularly for serum lipid profiles (such as triglycerides and cholesterol) and liver function enzymes (such as AST and ALT). These tests are conducted to help establish baseline levels for monitoring.


Q: Is Zoretanin safe to use in the summer or in sunny climates?

Patients taking this medicine are instructed to avoid intense sun exposure, including sunlamps and UV-tanning beds. This is because the medicine may cause photosensitivity, which can lead to an increased risk of sunburn.


Q: Does Zoretanin make your skin more sensitive to the sun?

Yes, official safety guidance warns that the medicine may increase photosensitivity in the skin. This increased sensitivity means the skin may be more susceptible to burning upon exposure to sunlight.


Q: Can men use Zoretanin, or is it mainly for women?

Official prescribing information indicates the medicine is for non-pregnant patients aged 12 years and older, which includes both men and women. The most stringent safety measures, such as mandatory use of contraception, are specifically required for women of childbearing potential due to the high risk of birth defects.


Q: Does Zoretanin have an official black box warning?

Yes. In the United States, the FDA label contains a Boxed Warning, sometimes referred to as a black box warning. This highlights the absolute prohibition on use during pregnancy due to the risk of severe birth defects (teratogenicity) and the requirement of a restricted risk management program (REMS).


Q: Is Zoretanin used for any other skin conditions besides acne?

While the medicine is primarily approved for severe, treatment-resistant nodular acne, regulatory text notes that it is sometimes used to treat certain other severe skin diseases. The consideration of use for other conditions is based on a healthcare professional's assessment of the severity of the illness.


Q: Can Zoretanin be taken with topical treatments like benzoyl peroxide?

Official guidance often recommends avoiding co-administration with other skin-drying topical agents, such as benzoyl peroxide. This is because combining the treatments may increase skin irritation, redness, and dryness.


Q: Can Zoretanin be used by someone who is lactose intolerant?

Official drug product information lists all inactive ingredients, or excipients. Specific brand formulations of isotretinoin capsules do not typically contain lactose. However, they frequently contain derivatives of soya-bean oil, which is an absolute contraindication for individuals with known peanut or soya allergies.


Q: What is the required monitoring during Zoretanin treatment?

Regulatory guidelines in countries like the U.S. and those in Europe recommend monitoring serum lipid profiles and liver function enzymes frequently during the course of therapy. Official guidance generally suggests monitoring these values prior to treatment, one month after starting, and every three months thereafter.


Q: What happens if I stop taking Zoretanin suddenly?

Official regulatory guidance instructs the healthcare provider to discontinue treatment immediately if a patient experiences specific serious adverse effects, such as severe psychiatric symptoms or inflammatory bowel disease. In situations where immediate discontinuation is not required, the decision and process for stopping the treatment course are medically managed.


Q: Does Zoretanin affect night vision?

Yes, official safety information reports that decreased night vision (nyctalopia) has occurred during treatment. Due to the potential for sudden onset of this effect, official safety information includes warnings about driving or operating any vehicle at night.


Q: Can I donate blood while taking Zoretanin?

Official safety instructions state that patients must be informed not to donate blood during therapy and for one month following the discontinuation of the medicine. This restriction is in place to prevent the blood from being given to a pregnant patient, which could expose a fetus to the drug.


Q: How is Zoretanin different from tretinoin cream?

Zoretanin (isotretinoin) is an oral systemic retinoid, meaning it affects the entire body from the inside. In contrast, tretinoin (often in cream form) is a topical retinoid, meaning it is applied directly to the skin. Zoretanin is typically reserved for severe, resistant acne, while topical retinoids are used for less severe conditions.


Q: What are the restrictions on having cosmetic procedures (e.g., waxing, laser) while on Zoretanin?

Official warnings state that patients must avoid certain cosmetic procedures like waxing, dermabrasion, and laser resurfacing while taking this medicine and for at least 6 months after stopping. This is due to the risk that the medicine could cause the procedures to result in permanent scarring or severe skin irritation.


Q: Can I drink alcohol while taking Zoretanin?

Regulatory guidance notes that the concurrent consumption of alcohol requires caution. Alcohol consumption may heighten the risk of hypertriglyceridemia (excessively high fats in the blood), particularly for patients who may already have existing issues with lipid metabolism.


Q: Does Zoretanin interact with birth control pills?

Official regulatory warnings emphasize that female patients of childbearing potential are required to use two effective forms of contraception for the duration of treatment. The label does not indicate that isotretinoin itself compromises the effectiveness of oral contraceptives, but it does list St. John's Wort as a substance that may interfere with their effectiveness.


Q: Why are people required to enroll in a special risk management program for this medicine?

The mandatory risk management program (such as iPLEDGE in the U.S.) is required for female patients of childbearing potential because the medicine is strictly prohibited during pregnancy. The program is designed to prevent all pregnancies due to the medicine's extremely high risk of causing severe birth defects (teratogenicity).


Q: Is it safe to use Zoretanin if I have a history of high cholesterol?

Official safety information lists excessively high blood lipid values as an absolute contraindication for use. The medicine also requires special consideration and caution in patients with a history of lipid metabolism disorder, including high cholesterol. Regular monitoring of blood lipid levels is part of the established protocol.


Q: What are the long-term effects of Zoretanin use?

Long-term administration of this medicine is associated with documented skeletal changes, such as hyperostosis (excessive bone growth). Research also focuses on the long-term durability of the acne clearance and the risk of acne relapse or recurrence following the cessation of treatment.


Q: What does the term 'teratogenic' mean in relation to Zoretanin?

The term teratogenic means that the medicine has the capacity to cause severe birth defects (congenital abnormalities) in an unborn baby. Due to this teratogenicity, official documents place the medicine in the highest risk category for use during pregnancy, and all use by pregnant women is strictly prohibited.


Q: Is it necessary to moisturize constantly while taking Zoretanin?

Official safety documents classify dry skin and cheilitis (lip inflammation) as very common adverse reactions, affecting more than 1 in 10 individuals. The high frequency of these systemic drying effects means that the regular use of moisturizing products is typically part of symptom management.


Q: How does Zoretanin help with acne scarring?

Research indicates that achieving successful acne clearance during the course of treatment is associated with a lower subsequent incidence of new scarring. However, studies on pre-existing acne scars often report only variable and minimal objective changes during the active treatment period.


Q: Is Zoretanin treatment generally considered a 'cure' for acne?

Official research focuses on the durability of measured changes and the risk of acne relapse or recurrence following treatment, rather than defining the medicine as a 'cure.' Studies indicate that a higher total cumulative dose is associated with a reduced rate of relapse.


Q: Why is Zoretanin only available by prescription from a specialist?

The medicine is a highly potent, prescription-only drug used for skin conditions that are severe and resistant to conventional treatments. These factors contribute to its status as a treatment reserved for management by a qualified healthcare provider.


Q: Are the concerns about vision problems with Zoretanin permanent?

While many side effects resolve upon stopping the medicine, official safety warnings report rare instances of decreased night vision (nyctalopia) that have persisted after treatment was discontinued. Other serious, rare vision effects, such as those related to Benign Intracranial Hypertension, may also be assessed for permanence.


Q: How long do you need to be off Zoretanin before a surgery?

Official product information contains restrictions only for cosmetic procedures (waxing, laser) due to the risk of scarring, advising a wait of at least 6 months after stopping. The label does not specify a precise waiting period for other, non-cosmetic surgeries. The potential effect of the medicine on wound healing is a topic for discussion with the operating surgeon.

How should Zoretanin be stored and disposed of?

How to Store and Dispose of Zoretanin (Isotretinoin)

Zoretanin must be stored according to specific regulatory requirements to maintain the stability of the active ingredient, isotretinoin.

Storage Conditions

The medicine requires storage at a controlled room temperature, specifically between 59 to 86F (15 to 30C). The product must be protected from light and not frozen. It must remain in the original, tightly closed container until use. Furthermore, the product must be stored out of the sight and reach of children, as required for all prescription medications.

Disposal Instructions

To dispose of unused or expired Zoretanin, regulatory guidance prohibits flushing the medicine down a toilet or sink. The preferred method is using a drug take-back program. If this is unavailable, the capsules must be removed from their packaging, mixed with an undesirable substance, placed in a sealed container, and then discarded with household trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Zoretanin found in:

A-Z Index: